# Insulin medicines

Medicines that replace the insulin a diabetic body lacks.

Source page: https://www.materialinsights.org/products/p_insulin_medicines/

Health products · No. 68

- Electrical and chemical age
 Health products · Product

WHO said in 2021 that three multinational companies control more than 90% of the insulin market.

Chart: Illustration: Insulin medicines

##### Where it comes from

Chart: Map of where it comes from

Eli Lilly began selling the first commercial insulin product, Iletin, in 1923. In 1982 the FDA approved Humulin, a human insulin made by bacteria and the first FDA-approved recombinant drug of any kind, and Humalog, a rapid analogue, followed in 1996.

##### Three things to know

1. WHO says one out of every two people with type 2 diabetes who need insulin does not get it.
2. In 2022 US manufacturer gross prices per 100 units of insulin were on average 9.71 times those in 33 OECD comparison countries combined, and 2.33 times after estimated discounts.
3. A once-weekly basal insulin cut pens per patient from 22 to 5 a year in a French model by authors from Novo Nordisk and the consultancy Putnam.

##### The journey

1. 1 **Production**Yeast or bacteria carrying the human insulin gene make a precursor of the hormone
2. 2 **Conversion**An enzyme turns the precursor into human insulin, with a refolding stage in the E. coli route; some analogues are then chemically modified
3. 3 **Filling**The medicine is formulated and filled into vials, cartridges or pre-filled pens
4. 4 **Use**Injected under the skin: 22 pens a year for once-daily basal insulin against 5 for once-weekly, in a French model by Novo Nordisk and Putnam authors
5. 5 **End of life**In the UK, Novo Nordisk takes back used pens and sends them to Denmark, where the plastic is recycled

##### Go deeper pick a tab to open it in full

## Other sections

- [Working](https://www.materialinsights.org/products/p_insulin_medicines/prod-working/index.md)
- [Bill of materials](https://www.materialinsights.org/products/p_insulin_medicines/prod-bom/index.md)
- [Use case](https://www.materialinsights.org/products/p_insulin_medicines/prod-use/index.md)
- [Supply chain](https://www.materialinsights.org/products/p_insulin_medicines/prod-supply/index.md)
- [Footprint](https://www.materialinsights.org/products/p_insulin_medicines/prod-footprint/index.md)
- [Evolution](https://www.materialinsights.org/products/p_insulin_medicines/prod-evolution/index.md)
- [Interventions](https://www.materialinsights.org/products/p_insulin_medicines/prod-interventions/index.md)
